A1 Refereed original research article in a scientific journal
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
Authors: Heymer, Emma J.; Hawkins, Michael M.; Winter, David L.; Teepen, Jop C.; Sunguc, Ceren; Ronckers, Cécile M.; Allodji, Rodrigue S.; Alessi, Daniela; Sugden, Elaine; Belle, Fabiën N.; Bagnasco, Francesca; Byrne, Julianne; Bárdi, Edit; Garwicz, Stanislaw; Grabow, Desiree; Jankovic, Momcilo; Kaatsch, Peter; Kaiser, Melanie; Michel, Gisela; Schindera, Christina; Haddy, Nadia; Journy, Neige; Česen Mazić, Maja; Skinner, Roderick; Kok, Judith L.; Gunnes, Maria W.; Wiebe, Thomas; Sacerdote, Carlotta; Maule, Milena M.; Terenziani, Monica; Jakab, Zsuzsanna; Winther, Jeanette F.; Lähteenmäki, Päivi M.; Zadravec Zaletel, Lorna; Haupt, Riccardo; Kuehni, Claudia E.; Kremer, Leontien C.; de Vathaire, Florent; Hjorth, Lars; Reulen, Raoul C.
Publisher: Springer Nature
Publication year: 2024
Journal: British Journal of Cancer
Journal name in source: British Journal of Cancer
Volume: 130
Issue: 6
First page : 976
Last page: 986
ISSN: 0007-0920
eISSN: 1532-1827
DOI: https://doi.org/10.1038/s41416-024-02577-y
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://www.nature.com/articles/s41416-024-02577-y
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/386790060
Self-archived copy's licence: CC BY
Self-archived copy's version: Publisher`s PDF
Background: Childhood cancer survivors are at risk of subsequent gliomas and meningiomas, but the risks beyond age 40 years are uncertain. We quantified these risks in the largest ever cohort.
Methods: Using data from 69,460 5-year childhood cancer survivors (diagnosed 1940-2008), across Europe, standardized incidence ratios (SIRs) and cumulative incidence were calculated.
Results: In total, 279 glioma and 761 meningioma were identified. CNS tumour (SIR: 16.2, 95% CI: 13.7, 19.2) and leukaemia (SIR: 11.2, 95% CI: 8.8, 14.2) survivors were at greatest risk of glioma. The SIR for CNS tumour survivors was still 4.3-fold after age 50 (95% CI: 1.9, 9.6), and for leukaemia survivors still 10.2-fold after age 40 (95% CI: 4.9, 21.4). Following cranial radiotherapy (CRT), the cumulative incidence of a glioma in CNS tumour survivors was 2.7%, 3.7% and 5.0% by ages 40, 50 and 60, respectively, whilst for leukaemia this was 1.2% and 1.7% by ages 40 and 50. The cumulative incidence of a meningioma after CRT in CNS tumour survivors doubled from 5.9% to 12.5% between ages 40 and 60, and in leukaemia survivors increased from 5.8% to 10.2% between ages 40 and 50.
Discussion: Clinicians following up survivors should be aware that the substantial risks of meningioma and glioma following CRT are sustained beyond age 40 and be vigilant for symptoms.
Downloadable publication This is an electronic reprint of the original article. |  |
